Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis

Arthritis and Rheumatism

Volumn 39, Issue 9, 1996, Pages 1576-1587

  Ahrens, Diane ^a   Koch, Alisa E ^b   Pope, Richard M ^b   Stein Picarella, Monica ^a   Niedbala, Michael J ^a  

^a BAYER CORPORATION   (United States)

^b NORTHWESTERN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; MONOCLONAL ANTIBODY; TISSUE INHIBITOR OF METALLOPROTEINASE;

ADULT; ARTHRITIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PLASMA; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; SYNOVIUM;

EID: 0029790101     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780390919     Document Type: Article

References (61)

1. Buttle DJ: Lysosomal cysteine endopeptidases in the degradation of cartilage and bone. In, Immunopharmacology of Joints and Connective Tissue Textbook of Immunopharmacology. Edited by JT Dingle, ME Davies. London, Academic Press, 1994
2. Martel-Pelletier J, Pelletier J-P, Cloutier J-M, Howell DS, Ghandur-Mnaymneh L, Woessner JF Jr: Neutral proteases capable of proteoglycan digesting activity in osteoarthritic and normal human articular cartilage. Arthritis Rheum 27:305-312, 1984
3. Janusz MJ, Doherty NS: Degradation of cartilage matrix proteoglycan by human neutrophils involves both elastase and cathepsin G. J Immunol 146:3922-3928, 1991
4. Woessner JF: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5:2145-2154, 1991
5. Van Wart HE, Birkedal-Hansen H: The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci U S A 87:5578-5582, 1990
6. Harris ED, Welgus HG, Krane SM: Regulation of mammalian collagenases. Collagen Related Res 4:493-512, 1984
7. Horwitz AL, Hance AJ, Crystal RG: Granulocyte collagenase: selective digestion of type I to type III collagen. Proc Natl Acad Sci USA 74:897-901, 1977
8. Collier IE, Wilhelm SM, Eisen AZ, Marmer BL, Grant GA, Seltzer JL, Kronberger A, He CS, Bauer EA, Goldberg GI: H-ras oncogene transformed human bronchial epithelial cells (TBE-1) secrete a single metalloproteinase capable of degrading basement membrane collagen. J Biol Chem 263:6579-6587, 1988
9. Hibbs MS, Hasty KA, Kang AH, Mainardi CL: Biochemical and immunologic characterization of the secreted forms of human neutrophil gelatinase. J Biol Chem 260:2493-2500, 1984
10. Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA, Goldberg GI: SV-40 transformed human lung fibroblasts secrete a 92-kda type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem 264:17213-17221, 1989
11. Docherty AJ, Murphy G: The tissue metalloproteinase family and inhibitor TIMP: a study using cDNAs and recombinant proteins. Ann Rheum Dis 49:469-479, 1990
12. Pavloff N, Staskus PW, Kishnani NS, Hawkes SP: A new inhibitor of metalloproteinases from chicken: CHIMP-3 a third member of the TIMP family. Proc Natl Acad Sci U S A 267:17321-17326, 1992
13. Dayer J-M, Derochem B, Burrus B, Demczuk S, Dinarella CA: Human recombinant interleukin-1 stimulates collagenase and prostaglandin E-2 production by human synovial cells. J Clin Invest 77:645-648, 1986
14. Dayer J-M, Beutler B, Cerami A: Cachectin tumor necrosis factor stimulates collagenase and prostaglandin-E-2 production by human synovial cells and dermal fibroblasts. J Exp Med 162:2163-2168, 1985
15. Pelletier J-P, Martel-Pelletier J, Howell DS, Ghandur-Mnaymneh L, Enis JE, Woessner JF Jr: Collagenase and collagenolytic activity in human osteoarthritic cartilage. Arthritis Rheum 26:63-68, 1983
16. Murphy G, Hembry RM, Reynolds JJ: Characterization of a specific antiserum to rat stromelysin and demonstration of the synthesis of collagenase and stromelysin by stimulated rabbit articular chondrocytes. Collagen Related Res 6:351-364, 1986
17. Eechout Y, Delaisse JM, Vaes G: Direct extraction and assay of bone tissue collagenase and its relation to parathyroid-hormone induced bone resorption. Biochem J 239:793-796, 1986
18. Welgus HG, Campbell EJ, Bar-Shavit Z, Senior RM, Teitelbaum SL: Human alveolar macrophages produce a fibroblast-like collagenase and collagenase inhibitor. J Clin Invest 76:219-224, 1985
19. Weiss SJ, Peppin GJ: Collagenolytic metalloenzymes of the human neutrophil: characteristics, regulation and potential function in vivo. Biochem Pharmacol 35:3189-3197, 1986
20. Walakovits LA, Moore VL, Bhardwaj N, Gallick GS, Lark MW: Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee injury. Arthritis Rheum 35:35-42, 1992
21. Clark IM, Powell LK, Ramsey S, Hazleman BL, Cawston TE: The measurement of collagenase, tissue inhibitor of metalloproteinases (TIMP), and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 36:372-379, 1993
22. McCachren SS: Expression of metalloproteinases and metalloproteinase inhibitor in human arthritic synovium. Arthritis Rheum 34:1085-1093, 1991
23. Case JP, Sano H, Lafyatis R, Remmers EF, Kumkumian GK, Wilder RL: Transin/stromelysin expression in the synovium of rats with experimental erosive arthritis: in situ localization and kinetics of expression of the transformation-associated metalloproteinase in euthymic and athymic lewis rats. J Clin Invest 84:1731-1740, 1989
24. Hembry RM, Bagga MR, Murphy G, Henderson B, Reynolds JJ: Rabbit models of arthritis: immunolocalization of matrix metalloproteinases and tissue inhibitor of metalloproteinase in synovium and cartilage. Am J Pathol 143:628-642, 1993
25. Welgus HG, Campbell EJ, Cury JD, Eisen AZ, Senior RM, Wilhelm SM, Goldberg GI: Neutral metalloproteinases produced by human mononuclear phagocytes: enzyme profile, regulation, and expression during cellular development. J Clin Invest 86: 1496-1502, 1990
26. Weeks BS, Schnaper HW, Handy M, Holloway E, Kleinman H: Human T lymphocytes synthesize the 92 kDa type IV collagenase (gelatinase B). J Cell Physiol 157:644-649, 1993
27. Unemori EN, Hibbs MS, Amento EP: Constitutive expression of a 92-KD Gelatinase (type V collagenase) by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines. J Clin Invest 88:1656-1662, 1991
28. Stahle-Backdahl M, Inoue M, Gludice GJ, Parks WC: 92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen. J Clin Invest 93:2022-2030, 1994
29. Reponen P, Sahlberg C, Munaut C, Thesleff I, Tryggvason K: High expression of 92-kD type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development. J Cell Biol 124: 1091-1102, 1994
30. Ogata Y, Pratta MA, Nagase H, Arner EC: Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) is induced in rabbit articular chondrocytes by cotreatment with interleukin 1beta and a protein kinase c activator. Exp Cell Res 201:245-249, 1992
31. I 92,000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells. Cancer Res 50:3872-3877, 1990
32. Hirose T, Reife RA, Smith GN Jr, Stevens RM, Mainardi CL, Hasty KA: Characterization of type V collagenase (gelatinase) in synovial fluid of patients with inflammatory arthritis. J Rheumatol 19:593-599, 1992
33. Picarella-Stein M, Ahrens D, Mase C, Golden H, Niedbala MJ: Localization and characterization of matrix metalloproteinase-9 in experimental rat adjuvant arthritis. Ann N Y Acad Sci 732:484-485, 1994
34. Steinbrocker O, Traeger CH, Batterman RC: Therapeutic criteria in rheumatoid arthritis. JAMA 140:659-662, 1949
35. Herzenherg LA, Herzenberg LA, Milstein C: Cell hybrids of myelomas with antibody forming cells and T lymphocytes. In, Handbook of Experimental Immunology. Edited by DM Weir. New York, Blackwell Scientific Publication, 1978
36. Lerner EA, Matis LA, Janeway CA, Jones PP, Schwartz RH, Murphy DB: Monoclonal antibody against an Ir gene product. J Exp Med 152:1085-1101, 1980
37. Koolwijk P, Miltenburg AMM, van Erck MGM, Oudshoorn M, Niedbala MJ, Breedveld FC, van Hinsbergh VVM: Activated gelatinase-B (MMP-9) and urokinase-type plasminogen activator in synovial fluids of patients with arthritis: correlation with clinical and experimental variables of inflammation. J Rheumatol 22:385-393, 1995
38. Sasaki S, Iwata H, Ishiguro N, Obata K, Miura T: Detection of stromelysin in synovial fluid and serum from patients with rheumatoid arthritis and osteoarthritis. Clin Rheumatol 13:228-233, 1994
39. Lohmander LS, Roos H, Dahlberg L, Hoerrner LA, Lark MW: Temporal patterns of stromelysin-1, tissue inhibitor and proteoglycan fragments in human knee joint fluid after injury to the cruciate ligament or meniscus. Ann Orthop Res 12:21-28, 1994
40. Dahlberg L, Friden T, Roos H, Lark MW, Lohmander LS: A longitudinal study of cartilage matrix metabolism in patients with cruciate ligament rupture-synovial fluid concentrations of aggrecan fragments, stromelysin-1 and tissue inhibitor of metalloproteinase-1. Br J Rheumatol 33:1107-1111, 1994
41. Taylor DJ, Cheung NT, Dawes PT: Increased serum proMMP-3 in inflammatory arthrides: a potential indicator of synovial inflammatory monokine activity. Ann Rheum Dis 53:768-772, 1994
42. Manicourt D-H, Fujimoto N, Obata K, Thonar EJ-MA: Serum levels of collagenase, stromelysin-1, and TIMP-1: age- and sex-related differences in normal subjects and relationship to the extent of joint involvement and serum levels of antigenic keratan sulfate in patients with osteoarthritis. Arthritis Rheum 37:1774-1783, 1994
43. Zucker S, Lysik RM, Zarrabi MH, Greenwald RA, Gruber B, Tickle SP, Baker TS, Doucherty AJP: Elevated plasma stromelysin levels in arthritis. J Rheumatol 21:2329-2333, 1994
44. Gijbels K, Masure S, Carton H, Opdenakker G: Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders. J Neuroimmunol 41:29-34, 1992
45. Overall CM, Sodek J, McCulloch CAG, Birek P: Evidence for polymorphonuclear leukocyte collagenase and 92-kilodalton gelatinase in gingival crevicular fluid. Infect Immun 59:4687-4692, 1991
46. Zucker S, Lysik RM, Zarrabi MH, Moll U: Mr 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer. Cancer Res 53:140-146, 1993
47. Woolley DE, Crossley MJ, Evanson JM: Collagenase at sites of cartilage erosion in the rheumatoid joint. Arthritis Rheum 20: 1231-1239, 1977
48. Okada Y, Takeuchi N, Tomita K, Nakanishi I, Nagase H: Immunolocalization of matrix metalloproteinase-3 (stromelysin-1) in rheumatoid synovioblasts (B cells) correlation with rheumatoid arthritis. Ann Rheum Dis 48:645-653, 1989
49. Gravallese EM, Darling JM, Ladd AL, Katz JN, Glimcher LH: In situ hybridization studies of stromelysin and collagenase messenger RNA expression in rheumatoid synovium. Arthritis Rheum 34:1076-1084, 1991
50. Tetlow LC, Lees M, Ogata Y, Nagase H, Wooley DE: Differential expression of gelatinase B (MMP-9) and stromelysin-1 (MMP-3) by rheumatoid synovial cells in vitro and in vivo. Rheumatol Int 13:53-59, 1993
51. Mohtai M, Smith RL, Schuman DJ, Tsuji Y, Torti F, Hutchinson NI, Stetler-Stevenson WG, Goldberg GI: Expression of 92-kD type IV collagenase/gelatinase (gelatinase b) in osteoarthritic cartilage and its induction in normal human articular cartilage by interleukin 1. J Clin Invest 92:179-185, 1993
52. Cawston TE, Mercer E, De Silva M, Hazleman BL: Metalloproteinases and collagenase inhibitors in rheumatoid synovial fluid. Arthritis Rheum 27:285-290, 1984
53. Firestein GS, Paine MM, Littman BH: Gene expression (collagenase, tissue inhibitor of metalloproteinases, complement, and HLA-DR) in rheumatoid arthritis and osteoarthritis synovium: quantitative analysis and effect of intraarticular corticosteroids. Arthritis Rheum 34:1094-1105, 1991
54. Reife RA, Hasty KA, Mainardi CL, Stuart JM: Immunolocalization of metalloproteinases in collagen autoimmune arthritis. Matrix Suppl 1:397, 1992
55. Meijers MHM, Koopdonk-Kool J, Meacock SCR, van Noorden CJF, Bunning RAD, Billingham MEJ: Cysteine proteinase activity in the development of arthritis in an adjuvant model of the rat. Agents Actions 39:C219-C221, 1993
56. Murphy G, Hembry RM, McGarrity M, Reynolds JJ, Henderson B: Gelatinase (type IV collagenase) immunolocalization in cells and tissues: use of an antiserum to rabbit bone gelatinase that identifies high and low Mr forms. J Cell Sci 92:487-495, 1989
57. Singer I, Kawka DW, Bayne EK, Donatelli SA, Weidner JR, Williams HR, Ayala JM, Mumford RA, Lark MW, Glant TT, Nabozny GH, David CS: VDIPEN, a metalloproteinase-generated neoepitope, is induced and immunolocalized in articular cartilage during inflammatory arthritis. J Clin Invest 95:2178-2186, 1995
58. Dean DD, Martel-Pellitier J, Pellitier J-P, Howell DS, Woessner JF: Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage. J Clin Invest 84:678-685, 1989
59. Dodge GR, Poole AR: Immunohistochemical detection and immunohistochemical analysis of type II collagen degradation in human normal, rheumatoid, and osteoarthritic articular cartilages and in explants of bovine articular cartilage cultured with interleukin-1. J Clin Invest 83:647-661, 1989
60. Lohmander LS, Hoerrner LA, Lark MW: Metalloproteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritis. Arthritis Rheum 36:181-189, 1993
61. Lohmander LS, Roos H, Dahlberg L, Hoerrner LA, Lark MW: Temporal patterns of stromelysin-1, tissue inhibitor, and proteoglycan fragments in human knee joint fluid after injury to the cruciate ligament or meniscus. J Orthop Res 12:21-28, 1994